Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moxham

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The New Biologist|February 1, 1991
Hybrid receptorsS Jacobs, C Moxham
AIDS (London, England)|August 16, 2001
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adultsJ A Bartlett, R DeMasi, J Quinn, et al.
Journal of Medicinal Chemistry|August 28, 1999
PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenesJ Wrobel, J Sredy, C Moxham, et al.
Journal of Medicinal Chemistry|February 7, 2001
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic propertiesM S Malamas, J Sredy, C Moxham, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1G M Szczech, P Furman, G R Painter, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The New Biologist|February 1, 1991
Hybrid receptorsS Jacobs, C Moxham
AIDS (London, England)|August 16, 2001
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adultsJ A Bartlett, R DeMasi, J Quinn, et al.
Journal of Medicinal Chemistry|August 28, 1999
PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenesJ Wrobel, J Sredy, C Moxham, et al.
Journal of Medicinal Chemistry|February 7, 2001
Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic propertiesM S Malamas, J Sredy, C Moxham, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1G M Szczech, P Furman, G R Painter, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
Pageof 1